These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2313144)

  • 1. [Clinical significance of CA19-9 for endometriosis].
    Watanabe J; Johboh T; Hata H; Kuramoto H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):155-61. PubMed ID: 2313144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.
    Toki T; Kubota J; Lu X; Nakayama K
    Acta Obstet Gynecol Scand; 2000 Sep; 79(9):771-6. PubMed ID: 10993101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of measurement of serum CA125 levels in diagnosing and treating endometriosis].
    Kobayashi H; Kanayama N; Hayata T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1054-60. PubMed ID: 3475378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma].
    Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical analysis of CA19-9, SLX, and CA125 in adenoid cystic carcinoma of trachea and bronchus].
    Tamura S; Yamaguchi K; Terada M; Nakano T; Maeda J; Iwahashi N; Hada T; Higashino K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Mar; 30(3):407-11. PubMed ID: 1314919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma.
    Takeshima N; Shimizu Y; Umezawa S; Hirai Y; Chen JT; Fujimoto I; Yamauchi K; Hasumi K
    Gynecol Oncol; 1994 Sep; 54(3):321-6. PubMed ID: 8088608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of the increase in the serum CA125 concentration in patients with endometriosis].
    Kobayashi H; Miyake W; Yamashita M; Kanayama N; Hayata T; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):467-72. PubMed ID: 3163715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
    Kataoka T; Watanabe Y; Hoshiai H
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
    Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary research on saliva and serum CA125 assays for detecting malignant ovarian tumors].
    Chen DX; Li FQ
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):84-5, 123-4. PubMed ID: 2364796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].
    Nakamura H; Katsumi T; Nagata S; Saito M; Konaka C; Kato H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1425-29. PubMed ID: 9567093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis.
    Harada T; Kubota T; Aso T
    Fertil Steril; 2002 Oct; 78(4):733-9. PubMed ID: 12372448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of a new serum tumor marker CA602 in ovarian cancers].
    Suzuki M; Sekiguchi I; Ohwada M; Aida I; Tamada T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1454-60. PubMed ID: 2170549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between tumor markers and clinical symptoms in ovarian cancer].
    Yakushiji M; Nishimura H
    Rinsho Byori; 1992 Apr; 40(4):354-8. PubMed ID: 1593760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant increases in serum CA125 and CA19-9 following torsion from an adenofibroma of the ovary: a case report.
    Fujiwara K; Moriya T; Mikami Y; Hiratsuka J; Sawada S; Imajo Y; Kohno I
    Jpn J Clin Oncol; 1994 Apr; 24(2):116-9. PubMed ID: 8158859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.